Skip to main content

Butamben

ADVERTISEMENT
Identification
Molecular formula
C15H23NO2
CAS number
94-25-7
IUPAC name
2-(dimethylamino)ethyl 4-(butylamino)benzoate
State
State

Butamben is a solid at room temperature.

Melting point (Celsius)
60.00
Melting point (Kelvin)
333.15
Boiling point (Celsius)
373.00
Boiling point (Kelvin)
646.15
General information
Molecular weight
278.39g/mol
Molar mass
278.3870g/mol
Density
1.0380g/cm3
Appearence

Butamben is typically a white to off-white crystalline powder.

Comment on solubility

Solubility of 2-(Dimethylamino)ethyl 4-(butylamino)benzoate

The solubility of 2-(dimethylamino)ethyl 4-(butylamino)benzoate (C15H23NO2) can be quite intriguing due to its structural properties. As a chemical compound with both organic and amino groups, it shows a range of solubility characteristics that are worth discussing:

  • Polar vs. Non-Polar Solubility: The presence of the dimethylamino and butylamino groups contributes to the compound's ability to interact with both polar and non-polar solvents. This dual nature suggests it may dissolve to some extent in water (polar) as well as in organic solvents like ethanol or chloroform (non-polar).
  • Temperature Effect: Generally, as temperature increases, solubility increases. Therefore, if testing this compound's solubility, it is advisable to conduct experiments at various temperatures to observe changes.
  • Potential Intramolecular Interactions: The interactions within the molecule, such as hydrogen bonding between the amino groups and potential dipole moments, can influence overall solubility. It might preferentially dissolve in solvents that can engage in similar hydrogen bonding.
  • Concentration Considerations: As with many compounds, solubility can diminish with increasing concentration, leading to precipitation under certain conditions.

In summary, the solubility of 2-(dimethylamino)ethyl 4-(butylamino)benzoate is likely influenced by its mixed polarity and structural interactions. Understanding these factors is key to predicting its behavior in various solvents.

Interesting facts

Interesting Facts about 2-(Dimethylamino)ethyl 4-(butylamino)benzoate

2-(Dimethylamino)ethyl 4-(butylamino)benzoate is a fascinating compound that holds a significant place in the realm of chemistry due to its unique structure and potential applications. Here are some captivating insights about this compound:

  • Structural Complexity: The compound features a complex molecular architecture that includes both amine and benzoate functional groups, which are essential for its biological interactions.
  • Pharmaceutical Potential: Due to the presence of the dimethylamino and butylamino groups, this compound is of interest in medicinal chemistry. It may have potential applications as a drug, particularly in areas related to neurological functions.
  • Synthesis Enthusiasm: The synthesis of this compound often requires a keen understanding of organic synthesis techniques. This can involve methods such as nucleophilic substitution and esterification, which are pivotal in constructing complex molecules in laboratories.
  • Activity Insight: The amine groups suggest that it may interact with various receptors in biological systems. Compounds like this are often studied for their ability to modulate effects in neurotransmitter systems.
  • Research Applications: Researchers might explore its properties in various studies, including pharmacodynamics and pharmacokinetics, which are essential for drug development and understanding its behavior in biological systems.

As stated by renowned chemist Linus Pauling, "The best way to have a good idea is to have lots of ideas." In exploring compounds like 2-(dimethylamino)ethyl 4-(butylamino)benzoate, scientists uncover layers of knowledge that may lead to breakthroughs in healthcare and materials science.

This compound is a prime example of how simple modifications to molecular structures can lead to significant changes in properties and functionalities, making it a valuable subject of study for both students and established scientists alike.

Synonyms
tetracaine
94-24-6
Amethocaine
2-(Dimethylamino)ethyl 4-(butylamino)benzoate
Pontocaine
Dicaine
Laudocaine
Metraspray
Tetracaina
Tetrakain
Anetain
Uromucaesthin
Contralgin
Fissucain
Intercain
Meethobalm
Mucaesthin
Rexocaine
Tetracainum
Dicain
Medihaler-Tetracaine
Medicaine
Niphanoid
Dikain
2-(Dimethylamino)ethyl p-(butylamino)benzoate
p-Butylaminobenzoyl-2-dimethylaminoethanol
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure
Tetracainum [INN-Latin]
Dimethylaminoethyl p-butyl-aminobenzoate
Tetracaina [INN-Spanish]
CHEBI:9468
Amethocaine HCl
EINECS 202-316-6
MFCD00053787
4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester
UNII-0619F35CGV
BRN 2216051
BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove
0619F35CGV
CHEMBL698
Tetracaine [USP:INN:BAN]
DTXSID1043883
SYNERA COMPONENT TETRACAINE
4-14-00-01172 (Beilstein Handbook Reference)
Tetrakain [Czech]
p-(butylamino)benzoic acid beta-(dimethylamino)ethyl ester
Tetracainum (INN-Latin)
Tetracaina (INN-Spanish)
TETRACAINE (MART.)
TETRACAINE [MART.]
TETRACAINE (USP-RS)
TETRACAINE [USP-RS]
Tetracaine (USP:INN:BAN)
TETRACAINE (EP MONOGRAPH)
TETRACAINE [EP MONOGRAPH]
TETRACAINE (USP MONOGRAPH)
TETRACAINE [USP MONOGRAPH]
100311-22-6
Amethocaine (TN)
Tetracaine (USP/INN)
NCGC00016049-02
CAS-136-47-0
Landocaine
Tetracain
Tetracaine cream
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]
FranklyNumb 3
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]
TE4
Burn Solution Cream
Spectrum_001032
Pantocaine (Salt/Mix)
Numfast Tetracaine Green
TETRACAINE [INN]
Prestwick0_000571
Prestwick1_000571
Prestwick2_000571
Prestwick3_000571
Spectrum2_001328
Spectrum3_000562
Spectrum4_000351
Spectrum5_001072
Lopac-T-7508
TETRACAINE [VANDF]
Epitope ID:174843
BLT 3
TETRACAINE [WHO-DD]
Lopac0_001211
SCHEMBL34714
BSPBio_000382
BSPBio_001944
KBioGR_000781
KBioSS_001512
DivK1c_000607
SPBio_001455
SPBio_002601
BPBio1_000422
TETRACAINE [GREEN BOOK]
Tetracaine, >=98% (TLC)
DTXCID9023883
TETRACAINE [ORANGE BOOK]
KBio1_000607
KBio2_001512
KBio2_004080
KBio2_006648
KBio3_001444
C05AD02
D04AB06
N01BA03
S01HA03
NINDS_000607
BCPP000048
ALBB-025902
BCP04777
HY-A0079
BDBM50017659
STL483844
TETRACAINE COMPONENT OF SYNERA
AKOS015889234
AC-3480
CCG-205285
DB09085
SDCCGSBI-0051178.P005
IDI1_000607
NCGC00016049-01
NCGC00016049-03
NCGC00016049-04
NCGC00016049-14
NCGC00162367-01
AS-81743
DA-78348
FT177996
SY066710
BCP0726000001
SBI-0051178.P004
AB00053549
NS00008930
T2789
Tetracaine, meets USP testing specifications
.beta.-Dimethylaminoethyl p-butylaminobenzoate
C07526
D00551
2-(Dimethylamino)ethyl 4-(butylamino)benzoate #
AB00053549-11
AB00053549_12
AB00053549_13
EN300-6748839
Q419608
aniline, N-butyl-4-(2-dimethylaminoethoxycarbonyl)-
Diathylaminoathanol ester der p-butylaminobenzosaure
BRD-K45071273-003-05-8
BRD-K45071273-003-15-7
BRD-K45071273-003-24-9
BRD-K45071273-003-25-6
Tetracaine, United States Pharmacopeia (USP) Reference Standard
benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester ,hydrochloride
BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
202-316-6
InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H